c22 Sphingomyelin (d18:1/22:0)
CAS:
Ref. 3D-UDA35912
1mg
1,048.00€
5mg
2,883.00€
10mg
4,613.00€
25mg
8,649.00€
50mg
13,838.00€
Product Information
Name:c22 Sphingomyelin (d18:1/22:0)
Brand:Biosynth
Description:C22 Sphingomyelin (d18:1/22:0) is a type of sphingolipid that has been studied for its potential in cancer treatment. It has been shown to have anticancer properties by inducing apoptosis or programmed cell death in cancer cells. In addition, it can inhibit the activity of certain kinases, which are enzymes that play a role in tumor growth and progression. This sphingomyelin analog has been tested on human and Chinese hamster ovary cells and has demonstrated efficacy against various types of tumors, including breast and colon cancer. Furthermore, it has been found to be an inhibitor of hyaluronan-mediated motility receptor, which is involved in cancer cell migration and invasion. C22 Sphingomyelin (d18:1/22:0) is a promising candidate for the development of kinase inhibitors for the treatment of cancer.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:787.2 g/mol
Formula:C45H91N2O6P
Purity:Min. 95%
Technical inquiry about: c22 Sphingomyelin (d18:1/22:0)
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.